Survival analysis arises in many fields of study including
medicine, biology, engineering, public health,
epidemiology, and economics. This book provides a
comprehensive treatment of Bayesian survival analysis.
Several topics are addressed, including parametric models,
semiparametric models based on prior processes,
proportional and non-proportional hazards models, frailty
models, cure rate models, model selection and comparison,
joint models for longitudinal and survival data, models
with time varying covariates, missing covariate data,
design and monitoring of clinical trials, accelerated
failure time models, models for mulitivariate survival
data, and special types of hierarchial survival models.
Also various censoring schemes are examined including right
and interval censored data. Several additional topics are
discussed, including noninformative and informative prior
specificiations, computing posterior qualities of interest,
Bayesian hypothesis testing, variable selection, model
selection with nonnested models, model checking techniques
using Bayesian diagnostic methods, and Markov chain Monte
Carlo (MCMC) algorithms for sampling from the posteiror and
predictive distributions. The book presents a balance
between theory and applications, and for each class of
models discussed, detailed examples and analyses from case
studies are presented whenever possible. The applications
are all essentially from the health sciences, including
cancer, AIDS, and the environment. The book is intended as
a graduate textbook or a reference book for a one semester
course at the advanced masters or Ph.D. level. This book
would be most suitable for second or third year graduate
students in statistics or biostatistics. It would also
serve as a useful reference book for applied or theoretical
researchers as well as practitioners.
Contents
- Introduction
- Parametric Models
- Semiparametric Models
- Fraility Models
- Cure Rate Models
- Model Comparison
- Joint Models for Longitudinal and Survival Data
- Missing Covariate Data
- Design and Monitoring of Randomized Clinical
Trials
- Other Topics